Source:http://linkedlifedata.com/resource/pubmed/id/12435620
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2002-11-18
|
pubmed:abstractText |
Under antidepressive treatment with amitryptiline (100 mg/d) a 71-year old woman developed delirious symptoms, hyponatremia and a grand mal seizure followed by cardiovascular arrest. A few month later she ingested 48 mg reboxetine with suicidal intent. Overdosing of reboxetine, a selective noradrenaline re-uptake inhibitor, proceeded without complications.
|
pubmed:language |
eng
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amitriptyline,
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents, Tricyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Morpholines,
http://linkedlifedata.com/resource/pubmed/chemical/reboxetine
|
pubmed:status |
MEDLINE
|
pubmed:author | |
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
415-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:articleTitle |
Superior safety of reboxetine over amitryptiline in the elderly.
|
pubmed:affiliation |
Dept. of Biological Psychiatry and Neuroscience, Evangl. Clinics Gelsenkirchen, Ruhr-University of Bochum, Munckelstr, Germany. EurJMedRes@t-online.de
|